Progenitor Cell Line (hPheo1) Derived from a Human Pheochromocytoma Tumor

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Ghayee, Hans K ^a   Bhagwandin, Vikash J ^b   Stastny, Victor ^a   Click, Arielle ^c   Ding, Liang Hao ^a   Mizrachi, Dario ^d   Zou, Ying S ^e   Chari, Raj ^f   Lam, Wan L ^g   Bachoo, Robert M ^a   Smith, Alice L ^a   Story, Michael D ^a   Sidhu, Stan ^h   Robinson, Bruce G ^h   Nwariaku, Fiemu E ^a   Gazdar, Adi F ^a   Auchus, Richard J ⁱ   Shay, Jerry W ^c,j  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d Cornell University   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g BRITISH COLUMBIA CANCER AGENCY   (Canada)

^h UNIVERSITY OF SYDNEY   (Australia)

ⁱ UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^j KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CD31 ANTIGEN; CHROMOGRANIN A; DEXAMETHASONE; LENTIVIRUS VECTOR; NERVE CELL ADHESION MOLECULE; NERVE GROWTH FACTOR; PHENYLETHANOLAMINE N METHYLTRANSFERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; ARTICLE; BIOCHEMISTRY; CANCER CELL CULTURE; CELL COUNT; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL POPULATION; CELL STRUCTURE; DIPLOIDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; PHEOCHROMOCYTOMA CELL; PROTEIN EXPRESSION; STEM CELL; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

ABNORMAL KARYOTYPE; ADULT; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOPHENOTYPING; NEOPLASTIC STEM CELLS; PHEOCHROMOCYTOMA; RNA INTERFERENCE; TELOMERASE; TRANSCRIPTOME; TRANSDUCTION, GENETIC;

LENTIVIRUS;

EID: 84878986491     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065624     Document Type: Article

References (32)

1. Elder EE, Elder G, Larsson C, (2005) Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor. J Surg Oncol 89: 193-201.
2. Ghayee HK, Wyne KL, Yau FS, Snyder WH 3rd, Holt S, et al (2008) The many faces of pheochromocytoma. J Endocrinol Invest 31: 450-458.
3. Adjalle R, Plouin PF, Pacak K, Lehnert H, (2009) Treatment of malignant pheochromocytoma. Horm Metab Res 41: 687-696.
4. Joshua AM, Ezzat S, Asa SL, Evans A, Broom R, et al. (2009) Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma. J Clin Endocrinol Metab 94: 5-9.
5. Qin Y, Yao L, King EE, Buddavarapu K, Lenci RE, et al. (2010) Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet 42: 229-233.
6. Comino-Mendez I, Gracia-Aznarez FJ, Schiavi F, Landa I, Leandro-Garcia LJ, et al. (2011) Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat Genet 43: 663-667.
7. Hao HX, Khalimonchuk O, Schraders M, Dephoure N, Bayley JP, et al. (2009) SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 325: 1139-1142.
8. Zhuang Z, Yang C, Lorenzo F, Merino M, Fojo T, et al. (2012) Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia. N Engl J Med 367: 922-930.
9. John H, Ziegler WH, Hauri D, Jaeger P, (1999) Pheochromocytomas: can malignant potential be predicted? Urology 53: 679-683.
10. Stenstrom G, Ernest I, Tisell LE, (1988) Long-term results in 64 patients operated upon for pheochromocytoma. Acta Med Scand 223: 345-352.
11. Greene LA, Tischler AS, (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A 73: 2424-2428.
12. Powers JF, Evinger MJ, Tsokas P, Bedri S, Alroy J, et al. (2000) Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice. Cell Tissue Res 302: 309-320.
13. Martiniova L, Lai EW, Elkahloun AG, Abu-Asab M, Wickremasinghe A, et al. (2009) Characterization of an animal model of aggressive metastatic pheochromocytoma linked to a specific gene signature. Clin Exp Metastasis 26: 239-250.
14. Pfragner R, Behmel A, Smith DP, Ponder BA, Wirnsberger G, et al. (1998) First continuous human pheochromocytoma cell line: KNA. Biological, cytogenetic and molecular characterization of KNA cells. J Neurocytol 27: 175-186.
15. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, et al. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352.
16. Ramirez RD, Sheridan S, Girard L, Sato M, Kim Y, et al. (2004) Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res 64: 9027-9034.
17. Lewis CM, Herbert BS, Bu D, Halloway S, Beck A, et al. (2006) Telomerase immortalization of human mammary epithelial cells derived from a BRCA2 mutation carrier. Breast Cancer Res Treat 99: 103-115.
18. Vaughan MB, Ramirez RD, Andrews CM, Wright WE, Shay JW, (2009) H-ras expression in immortalized keratinocytes produces an invasive epithelium in cultured skin equivalents. PLoS One 4: e7908.
19. Tait JF, Tait SA, Gould RP, Mee MS, (1974) The properties of adrenal zona glomerulosa cells after purification by gravitational sedimentation. Proc R Soc Lond B Biol Sci 185: 375-407.
20. Haning R, Tait SA, Tait JF, (1970) In vitro effects of ACTH, angiotensins, serotonin and potassium on steroid output and conversion of corticosterone to aldosterone by isolated adrenal cells. Endocrinology 87: 1147-1167.
21. Marian CO, Cho SK, McEllin BM, Maher EA, Hatanpaa KJ, et al. (2010) The telomerase antagonist, imetelstat, efficiently targets glioblastoma tumor-initiating cells leading to decreased proliferation and tumor growth. Clin Cancer Res 16: 154-163.
22. Gazdar AF, Oie HK, (1986) Re: Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Cancer Res 46: 6011-6012.
23. Thompson F (1997) Cytogenetic methods and findings in human solid tumors; Barch M, editor: Lipincott-Raven.
24. Gazdar AF, Girard L, Lockwood WW, Lam WL, Minna JD, (2010) Lung cancer cell lines as tools for biomedical discovery and research. J Natl Cancer Inst 102: 1310-1321.
25. Ding LH, Xie Y, Park S, Xiao G, Story MD, (2008) Enhanced identification and biological validation of differential gene expression via Illumina whole-genome expression arrays through the use of the model-based background correction methodology. Nucleic Acids Res 36: e58.
26. Chung KF, Sicard F, Vukicevic V, Hermann A, Storch A, et al. (2009) Isolation of neural crest derived chromaffin progenitors from adult adrenal medulla. Stem Cells 27: 2602-2613.
27. Aguiar RC, Dahia PL, Sill H, Toledo SP, Goldman JM, et al. (1996) Deletion analysis of the p16 tumour suppressor gene in phaeochromocytomas. Clin Endocrinol (Oxf) 45: 93-96.
28. Muscarella P, Bloomston M, Brewer AR, Mahajan A, Frankel WL, et al. (2008) Expression of the p16INK4A/Cdkn2a gene is prevalently downregulated in human pheochromocytoma tumor specimens. Gene Expr 14: 207-216.
29. van Nederveen FH, Korpershoek E, deLeeuw RJ, Verhofstad AA, Lenders JW, et al. (2009) Array-comparative genomic hybridization in sporadic benign pheochromocytomas. Endocr Relat Cancer 16: 505-513.
30. Hofland J, van Nederveen FH, Timmerman MA, Korpershoek E, de Herder WW, et al. (2007) Expression of activin and inhibin subunits, receptors and binding proteins in human pheochromocytomas: a study based on mRNA analysis and immunohistochemistry. Clin Endocrinol (Oxf) 66: 335-340.
31. Franquemont DW, Mills SE, Lack EE, (1994) Immunohistochemical detection of neuroblastomatous foci in composite adrenal pheochromocytoma-neuroblastoma. Am J Clin Pathol 102: 163-170.
32. Ribon V, Saltiel AR, (1996) Nerve growth factor stimulates the tyrosine phosphorylation of endogenous Crk-II and augments its association with p130Cas in PC-12 cells. J Biol Chem 271: 7375-7380.